In the effective anticoagulation with factor Xa next generation (ENGAGE) AF-TIMI 48 trial [16], stroke or SEE, major bleeding or death were infrequent and similar in patients medicated with edoxaban and warfarin [17]. Here, F10 is linked to Stroke.